Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells

Cord blood hematopoietic stem cells (CB-HSCs) transplantation has been increasing gradually with facing the limitation of insufficient quantity of HSCs in each CB unit. Therefore, efficient expansion methods which can maintain stem cell characteristics are needed. In this study, umbilical CB-CD34+ c...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamonnaree Chotinantakul, Patcharee Prasajak, Wilairat Leeanansaksiri
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2013/909812
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552669120561152
author Kamonnaree Chotinantakul
Patcharee Prasajak
Wilairat Leeanansaksiri
author_facet Kamonnaree Chotinantakul
Patcharee Prasajak
Wilairat Leeanansaksiri
author_sort Kamonnaree Chotinantakul
collection DOAJ
description Cord blood hematopoietic stem cells (CB-HSCs) transplantation has been increasing gradually with facing the limitation of insufficient quantity of HSCs in each CB unit. Therefore, efficient expansion methods which can maintain stem cell characteristics are needed. In this study, umbilical CB-CD34+ cells were cultured in two different cytokine cocktails: 4 factors (4F = Flt3-L, SCF, IL-6, and TPO) and 5 factors (5F = Wnt1 + 4F) in both serum and serum-free media. The data revealed that the best condition to accelerate an expansion of CD34+CD38− cells was serum-free culture condition supplemented with 5F (5F KSR). This condition yielded 24.3 ± 2.1 folds increase of CD34+CD38− cells. The expanded cells exhibited CD34+ CD38− CD133+ CD71low CD33low CD3− CD19− markers, expressed nanog, oct3/4, c-myc, and sox2 genes, and maintained differentiation potential into lymphoid, erythroid and myeloid lineages. The achievement of CD34+CD38− cells expansion may overcome an insufficient quantity of the cells leading to the improvement of the stem cell transplantation. Altogether, our findings highlight the role of Wnt1 and the new culture condition in stimulating hematopoietic stem/progenitor cells expansion which may offer a new therapeutic avenue for cord blood transplantation, regenerative medicine, stem cell bank applications, and other clinical applications in the future.
format Article
id doaj-art-c7939c61c8f640cbb70a4a829c97500c
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-c7939c61c8f640cbb70a4a829c97500c2025-02-03T05:58:13ZengWileyStem Cells International1687-966X1687-96782013-01-01201310.1155/2013/909812909812Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− CellsKamonnaree Chotinantakul0Patcharee Prasajak1Wilairat Leeanansaksiri2Stem Cell Therapy and Transplantation Research Group, Suranaree University of Technology, Nakhon Ratchasima 30000, ThailandStem Cell Therapy and Transplantation Research Group, Suranaree University of Technology, Nakhon Ratchasima 30000, ThailandStem Cell Therapy and Transplantation Research Group, Suranaree University of Technology, Nakhon Ratchasima 30000, ThailandCord blood hematopoietic stem cells (CB-HSCs) transplantation has been increasing gradually with facing the limitation of insufficient quantity of HSCs in each CB unit. Therefore, efficient expansion methods which can maintain stem cell characteristics are needed. In this study, umbilical CB-CD34+ cells were cultured in two different cytokine cocktails: 4 factors (4F = Flt3-L, SCF, IL-6, and TPO) and 5 factors (5F = Wnt1 + 4F) in both serum and serum-free media. The data revealed that the best condition to accelerate an expansion of CD34+CD38− cells was serum-free culture condition supplemented with 5F (5F KSR). This condition yielded 24.3 ± 2.1 folds increase of CD34+CD38− cells. The expanded cells exhibited CD34+ CD38− CD133+ CD71low CD33low CD3− CD19− markers, expressed nanog, oct3/4, c-myc, and sox2 genes, and maintained differentiation potential into lymphoid, erythroid and myeloid lineages. The achievement of CD34+CD38− cells expansion may overcome an insufficient quantity of the cells leading to the improvement of the stem cell transplantation. Altogether, our findings highlight the role of Wnt1 and the new culture condition in stimulating hematopoietic stem/progenitor cells expansion which may offer a new therapeutic avenue for cord blood transplantation, regenerative medicine, stem cell bank applications, and other clinical applications in the future.http://dx.doi.org/10.1155/2013/909812
spellingShingle Kamonnaree Chotinantakul
Patcharee Prasajak
Wilairat Leeanansaksiri
Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
Stem Cells International
title Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
title_full Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
title_fullStr Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
title_full_unstemmed Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
title_short Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
title_sort wnt1 accelerates an ex vivo expansion of human cord blood cd34 cd38 cells
url http://dx.doi.org/10.1155/2013/909812
work_keys_str_mv AT kamonnareechotinantakul wnt1acceleratesanexvivoexpansionofhumancordbloodcd34cd38cells
AT patchareeprasajak wnt1acceleratesanexvivoexpansionofhumancordbloodcd34cd38cells
AT wilairatleeanansaksiri wnt1acceleratesanexvivoexpansionofhumancordbloodcd34cd38cells